Lorenzini et al.
255
analyses were performed on a Carlo Erba 1108 analyzer.
ESI-MS were acquired in the positive ion mode on a Bruker
Esquire LC ion-trap mass spectrometer equipped with an
electrospray ion source; solvents used were acetone/MeOH
or CH2Cl2/MeOH, and the sample solution of concentration
~25–50 µmol/L was infused into the ion source by a syringe
pump at a flow-rate of 700 µL/h. MALDI-MS were obtained
on a Bruker Biflex IV MALDI-TOF spectrometer equipped
with a nitrogen laser. The samples were dissolved in ace-
tone/MeOH or CH2Cl2/MeOH and dithranol was used as
matrix. The sample solutions (~1 mg/mL) and the matrix
(20 mg/mL) were mixed in a ratio of 1:1 to 1:10, and 1 µL
of the mixture was deposited onto the sample target; these
spectra were acquired in the positive reflection mode with
delay extraction by averaging 100 laser shots, and were cali-
brated externally using peptides. MS data are reported as m/z
values. IR spectra were measured with a Thermo Nicolet
FT-IR Nexus spectrometer using either a KBr pellet or a so-
lution, as stated.
(16 mg, 0.069 mmol) in acetone (1.0 mL) and subsequent
stirring of the mixture at rt for 1 h generated a yellow solu-
tion. Addition of Et2O (20.0 mL) precipitated a yellow pow-
der that was collected, washed with Et2O (2 × 10 mL), and
dried in vacuo; the product is 4a (51 mg, 72% yield). IR
(KBr, cm–1): 3057 (νO-H), 2195 (νIr-H), 1587, 1579 (νC=N). IR
(acetone, cm–1): 2034 (νIr-H), 1581 (νC=N). 1H NMR (acetone-
2
d6) (see Scheme 2 for atom-labeling) δ: –15.48 (t, 1H, JHP
=
17.6, IrH), 8.94 (br s, 1H, OH), 7.51 (m, 5H, CH2C6H5),
7.39 (m, 15H, PC6H5), 7.27 (t, 1H, 3JHHa ~ 3JHHc ~ 7.3, Hb),
3
7.04 (m, 15H, PC6H5), 6.49 (d, 1H, JHHb ~ 7.2, Hc),
3
6.28 (d, 1H, JHHb ~ 7.4, Ha), 5.50 (br s, 2H, NCH2), 2.09
(br s, 3H, CH3), 2.09 (br m, 6H, (CH3)2CO). 13C{1H} NMR
(acetone-d6) δ: 183.26 (s, C(H)=N), 159.20 (s, Cd), 136.52
(s, C-OH), 134.25 (m, PC6H5), 133.31 (s, Ca), 132.71 (m,
CH2C6H5), 128.59 (m, PC6H5), 127.94 (s, Cb), 110.83 (s,
Cc), 56.99 (s, CH2Ph) 20.66 (s, CH3); the Ce signal could not
be assigned. 31P{1H} NMR (acetone-d6) δ: 17.91 (s, PPh),
1
–142.64 (spt, JPF = 707.3, PF6). MALDI-MS: 942 [M-PF6-
Me2CO]+, 679 [M – H-PF6-Me2CO-PPh3]+.
X-ray quality, yellow prism crystals of 4·2MeOH, as well
as a yellow precipitate of 4, were obtained at ~273 K from a
saturated MeOH (2.0 mL) solution of 4a; 4 was washed with
Et2O and dried in vacuo. Anal. calcd. for C52H49N4O2F6P3Ir
(4): C 55.81, H 4.41, N, 1.25; found: C 55.89, H 4.94, N
1.22.
[IrH{NH=C(Ph)(o-C6H4)}(HN=CPh2)(PPh3)2]PF6 (3)
A red suspension of [Ir(cod)(PPh3)2]PF6 (1) (61 mg,
0.063 mmol) in MeOH (1.8 mL) was reacted with 1 atm H2
at rt to generate immediately a brown solution containing
cis,trans,cis-[Ir(H)2(PPh3)2(MeOH)2]PF6 (2) (3, 4). HN=CPh2
(Im1) (22.0 µL, 0.127 mmol) in MeOH (0.5 mL) was then
added under H2. Stirring the mixture at rt for 90 min resulted
in precipitation of a yellow solid that was collected, washed
with Et2O (3 × 5 mL), and dried in vacuo (63 mg, 82%
yield). IR (KBr, cm–1): 3429 (νN-H), 2132 (νIr-H), 1589, 1560
(νC=N). IR (CH2Cl2, cm–1): 3340 (νN-H), 2195 (νIr-H), 1583,
[IrH{N(p-F-C6H4)=CH(o-C6H4)}(Me2CO)(PPh3)2]PF6
(5a)
A red solution of 1 (25 mg, 0.026 mmol) in acetone-d6 (or
acetone) (1.0 mL) was treated as above with H2 to form a
solution of 2a. Addition under Ar of PhC(H)=N(p-F-C6H4)
(Im3) (6 mg, 0.030 mmol) in acetone-d6 (or acetone)
(0.5 mL) at rt resulted in a yellow solution into which slow
diffusion of Et2O generated overnight a yellow, crystalline
powder (5a) and X-ray quality, yellow plate crystals of
5a·1/2Me2CO. The powder (5a) was collected, washed with
Et2O (3 × 5 mL), and dried in vacuo (24 mg, 83% yield). IR
(KBr, cm–1): 2206 (νIr-H), 1599 (νC=N). IR (CH2Cl2, cm–1):
1
1568 (νC=N). H NMR (CD2Cl2) (see Scheme 2 for atom-
2
labeling) δ: –15.80 (t, 1H, JHP = 14.1, IrH), 10.21 (s,
3
HN=C(o-C6H4)), 9.98 (s, HN=CPh2), 7.58 (t, 1H, JHHi
~
3
7.6, Hj), 7.43 (d, 1H, JHH = 7.3, Hd), 7.39–7.06 (m, 38H,
3
PC6H5, Hi, Hm, Hn), 6.86 (d, 2H, JHH = 7.7, Hl or Ho), 6.75
3
3
3
3
(t, 1H, JHHa ~ JHHc ≅ 7.3, Hb), 6.65 (t, 1H, JHHb ~ JHHd
~
=
3
3
7.2, Hc), 6.56 (d, 1H, JHH = 7.5, Ha), 6.37 (d, 2H, JHH
7.6, Hh), 6.28 (d, 2H, JHH = 7.5, Hl or Ho). 13C{1H} NMR
(CD2Cl2) δ: 189.40 (s, NH=C(o-C6H4)), 179.32 (s,
HN=CPh2), 151.59 (s, Cf), 147.32 (s, Ce), 142.04 (s, Cd),
137.97 (s, Ck or Cp), 137.01 (s, Ck or Cp), 134.69 and
131.88-127.93 (m, PC6H5, Ci, Cm, Cn), 133.82 (s, Ca),
131.18 (s, Cc), 129.86 (s, Cj), 129.43 (s, Cl or Co), 128.65 (s,
Ch), 128.64 (s, Cl or Co), 121.23 (s, Cb); the Cg signal could
not be assigned. 31P{1H} NMR (CD2Cl2) δ: 16.93 (s, PPh),
3
1
2217 (νIr-H), 1599, 1587 (νC=N). H NMR (acetone-d6) (see
2
Scheme 2 for atom-labeling) δ: –16.98 (t, 1H, JHP = 15.8,
IrH), 8.15 (br s, 1H, C(H)=N), 7.49 (m, 6H, C6H4F, Ha, Hd),
7.40–7.30, 7.19–7.09 (m, 30H, PC6H5), 6.87 (br t, 1H, Hb or
3
4
Hc), 6.55 (dt, 1H, JHH ~ 7.6, JHH ~ 1.2, Hb or Hc). 13C{1H}
NMR (acetone-d6) δ: 175.07 (s, C(H)=N), 146.88 (s, Ce),
131.43 (m, PC6H5), 129.42 (s, Cb or Cc), 128.84 (m, C6H4F,
–143.70 (spt, JPF = 712.0, PF6). ESI-MS: 1080 [M+], 899
1
Ca, Cd), 126.69 (m, PC6H5), 119.39 (s, Cb or Cc). 31P{1H}
[M+-NH=C(Ph)(o-C6H4)]. Anal. calcd. for C62H52N2F6P3Ir: C
60.83, H 4.28, N 2.29; found: C 60.87, H 4.30, N 2.18.
Yellow, X-ray quality tablet crystals of 3 were grown at rt
by diffusion of Et2O into a CH2Cl2 solution (1.5 mL) of the
complex (25 mg, 20.4 mmol).
1
NMR (acetone-d6) δ: 17.69 (s, PPh), –142.64 (spt, JPF
=
707.3, PF6). MALDI-MS: 917 [M-H-PF6-Me2CO]+. Anal.
calcd. for C52H48NOF7P3Ir: C 55.71, H 4.32, N 1.25; found:
C 55.37, H 4.18, N, 1.25.
Attempted reactions with (C6F5)C(H)=NPh (Im4)
[IrH{PhCH2N=C(Me)(o-C6H3OH)}(solv)(PPh3)2]PF6;
solv = MeOH (4), Me2CO (4a)
A red suspension of 1 (60 mg, 0.062 mmol) in acetone
(1.0 mL) was reacted with 1 atm H2 at rt to form a brown
solution of cis,trans,cis-[Ir(H)2(PPh3)2(Me2CO)2]PF6 (2a).2
Addition under Ar of (o-HOC6H4)C(Me)=NCH2Ph (Im2)
Solutions of 2 and 2a (and the corresponding species with
solv = CD3OD and acetone-d6, see Scheme 2) were made in
the appropriate solvents as described above, but using a
smaller quantity of 1 (15 mg, 0.016 mmol) in 0.5 mL of the
respective solvents. No rt reactions over several hours were
seen on addition of Im4 (5 mg, 0.017 mmol), the NMR spec-
2 All the complexes labelled with an ‘a’ have coordinated acetone.
© 2008 NRC Canada